Robert W. Baird restated their outperform rating on shares of Albemarle Corporation (NYSE:ALB) in a research report released on Tuesday morning, The Fly reports. They currently have a $135.00 target price on the specialty chemicals company’s stock, up from their previous target price of $125.00. The analysts noted that the move was a valuation call.
ALB has been the subject of a number of other research reports. Morgan Stanley lowered their price target on shares of Albemarle Corporation from $100.00 to $72.00 and set an equal weight rating for the company in a report on Thursday, May 25th. Royal Bank Of Canada reissued a buy rating and issued a $132.00 price objective on shares of Albemarle Corporation in a research report on Tuesday, April 18th. Needham & Company LLC reissued a buy rating and issued a $36.00 price objective on shares of Albemarle Corporation in a research report on Thursday, June 29th. KeyCorp increased their price objective on shares of Albemarle Corporation from $120.00 to $125.00 and gave the stock an overweight rating in a research report on Monday, June 12th. Finally, Aegis reissued a buy rating on shares of Albemarle Corporation in a research report on Friday, July 7th. Three equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of Buy and an average price target of $104.80.
Albemarle Corporation (ALB) opened at 117.73 on Tuesday. The stock has a 50 day moving average price of $110.61 and a 200 day moving average price of $103.88. The stock has a market cap of $13.04 billion, a P/E ratio of 28.61 and a beta of 1.58. Albemarle Corporation has a 12-month low of $75.11 and a 12-month high of $119.00.
Albemarle Corporation (NYSE:ALB) last announced its quarterly earnings results on Wednesday, May 3rd. The specialty chemicals company reported $1.05 EPS for the quarter, beating the Zacks’ consensus estimate of $0.95 by $0.10. Albemarle Corporation had a net margin of 17.02% and a return on equity of 11.97%. The firm had revenue of $722.06 million during the quarter, compared to the consensus estimate of $678.74 million. On average, analysts forecast that Albemarle Corporation will post $4.37 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “Albemarle Corporation’s (NYSE:ALB) “Outperform” Rating Reaffirmed at Robert W. Baird” was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this story can be read at https://stocknewstimes.com/2017/07/19/albemarle-corporations-nysealb-outperform-rating-reaffirmed-at-robert-w-baird.html.
The business also recently announced a quarterly dividend, which will be paid on Monday, October 2nd. Stockholders of record on Friday, September 15th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 1.09%. The ex-dividend date is Thursday, September 14th. Albemarle Corporation’s dividend payout ratio (DPR) is presently 31.22%.
In related news, CFO Scott Tozier sold 25,000 shares of Albemarle Corporation stock in a transaction that occurred on Friday, July 7th. The shares were sold at an average price of $110.13, for a total transaction of $2,753,250.00. Following the transaction, the chief financial officer now directly owns 57,506 shares of the company’s stock, valued at $6,333,135.78. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Karen G. Narwold sold 20,000 shares of Albemarle Corporation stock in a transaction that occurred on Monday, June 19th. The shares were sold at an average price of $108.16, for a total transaction of $2,163,200.00. Following the transaction, the executive vice president now directly owns 45,120 shares in the company, valued at $4,880,179.20. The disclosure for this sale can be found here. Over the last three months, insiders have sold 105,000 shares of company stock worth $11,499,850. 0.74% of the stock is currently owned by corporate insiders.
Institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. increased its stake in Albemarle Corporation by 6.3% in the first quarter. Vanguard Group Inc. now owns 12,287,799 shares of the specialty chemicals company’s stock valued at $1,298,083,000 after buying an additional 725,702 shares during the period. BlackRock Inc. increased its stake in Albemarle Corporation by 2,805.3% in the first quarter. BlackRock Inc. now owns 8,310,717 shares of the specialty chemicals company’s stock valued at $877,947,000 after buying an additional 8,024,668 shares during the period. State Street Corp increased its stake in Albemarle Corporation by 0.5% in the first quarter. State Street Corp now owns 6,356,839 shares of the specialty chemicals company’s stock valued at $671,675,000 after buying an additional 30,662 shares during the period. Jennison Associates LLC increased its stake in Albemarle Corporation by 14.0% in the first quarter. Jennison Associates LLC now owns 5,705,825 shares of the specialty chemicals company’s stock valued at $602,763,000 after buying an additional 702,388 shares during the period. Finally, FMR LLC increased its stake in Albemarle Corporation by 3.9% in the first quarter. FMR LLC now owns 2,269,067 shares of the specialty chemicals company’s stock valued at $239,703,000 after buying an additional 84,189 shares during the period. 86.16% of the stock is currently owned by institutional investors.
Albemarle Corporation Company Profile
Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.
Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
